Search for Clinical Trial Results

Dysgerminoma - 7 Studies Found
Status | Study |
Completed |
Study Name: Darbepoetin Alfa in Patients With "Poor Prognosis" Germ Cell Tumor Treated With High-Dose Chemotherapy (HD-VIP) Condition: Dysgerminoma Date: 2005-09-13 Interventions: Drug: Darbepoetin alfa |
Recruiting |
Study Name: Evaluating Immune Therapy, Duravalumab (MEDI4736) With Tremelimumab for Relapsed/Refractory Germ Cell Tumors Condition:
|
Terminated |
Study Name: Imatinib Mesylate in Treating Patients With Progressive, Refractory, or Recurrent Stage II or Stage III Testicular or Ovarian Cancer Condition:
|
Active, not recruiting |
Study Name: Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy Condition:
|
Completed |
Study Name: Combination Chemotherapy and Pegfilgrastim in Treating Patients With Previously Untreated Germ Cell Tumors Condition:
|
Completed |
Study Name: Sunitinib in Treating Patients With Metastatic Germ Cell Tumors That Have Relapsed or Not Responded to Treatment Condition:
Date: 2007-03-27 Interventions: Drug: sunitinib malate |
Completed |
Study Name: Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors Condition:
|